Sung-Soo Kim
Direttore/Membro del Consiglio presso BENO TNR, INC.
Patrimonio netto: - $ in data 30/04/2024
Provenienza dei contatti di primo grado di Sung-Soo Kim
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Semiconductors | 7 | |
| Public Company | Packaged Software | 7 | |
J&J Investment Co., Ltd.
 J&J Investment Co., Ltd. Miscellaneous Commercial ServicesCommercial Services J&J Investment Co. Ltd. provides management consulting services. The company was founded on April 2, 2002 and is headquartered in Pohang-si, South Korea.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sung-Soo Kim tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| WESTRISE CO., LTD. | Specialty Stores | Chief Executive Officer Comptroller/Controller/Auditor | |
| Seoul National University | College/University | Graduate Degree Undergraduate Degree | |
| Korea University | College/University | Graduate Degree | |
| Sungkyunkwan University | College/University | Graduate Degree | |
| SMEC CO.,LTD | Specialty Telecommunications | Director/Board Member | |
| SONID INC. | Electronic Equipment/Instruments | Director/Board Member Chief Executive Officer | |
| FUTURECORE CO.,LTD. | Semiconductors | Director/Board Member | |
Ildong Chemical Co., Ltd.
 Ildong Chemical Co., Ltd. Industrial ConglomeratesProducer Manufacturing Ildong Chemical Co., Ltd. is a South Korean company that manufactures chemical products. The private company is based in Daegu, South Korea. The CEO of the company is Keun-Ho Cho. | Industrial Conglomerates | Director/Board Member | |
| Exax Nfc Co. Ltd. | Director/Board Member | ||
Nano Pharmasolutions, Inc.
 Nano Pharmasolutions, Inc. Pharmaceuticals: MajorHealth Technology Nano Pharmasolutions, Inc. is a pharmaceutical company based in an undisclosed location. Nano Pharmasolutions is developing a dry powder for inhalation (DPI) formulation of remedesivir to fight COVID-19. The American company's platform is based on physical vapor deposition (PVD) technology, which allows them to make drug nanoparticles with no excipients or solvents. These nanodrug particles can be used in various forms such as pills, nasal sprays, creams/salves, inhalers, and eye drops. The private company's nanotransformer™ technology can create an e-8 torr vacuum, and it uses carrier solids selected from hydrophilic pharmaceutical excipients to deposit vapor phase drugs as nanoparticles on fast-moving carriers. The company was founded by Kay Olmstead, Saeyeon Lee, Seok-Keun Koh, and Kay Olmstead has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| Benobio Co., Ltd. | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Corea del Sud | 11 |
| Stati Uniti | 2 |
Settori
| Consumer Services | 4 |
| Electronic Technology | 3 |
| Retail Trade | 2 |
| Communications | 2 |
| Producer Manufacturing | 2 |
Posizioni
| Director/Board Member | 17 |
| Chief Executive Officer | 8 |
| Independent Dir/Board Member | 4 |
| Graduate Degree | 3 |
| Comptroller/Controller/Auditor | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| Jib-Hoon Jung | 8 |
| Jun-Young Cho | 4 |
| Chang-Hyun Kim | 4 |
| Jae-Jun Dong | 3 |
| Kyu-Young Lee | 2 |
| Kay Olmstead | 2 |
| Sung-Soo Kim | 1 |
| Seung-Woo Lee | 1 |
| Aldrin R Denny | 1 |
- Borsa valori
- Insiders
- Sung-Soo Kim
- Connessioni Società
